Back to search

A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients

Data up to Jan 2025

Published2010
Citations61
References28

Total Citations Per Year

Abstract

References (28)

Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

2007 • 2,814 citations

Calreticulin exposure dictates the immunogenicity of cancer cell death

2006 • 2,789 citations

Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes

2002 • 2,781 citations

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors

2009 • 1,694 citations

Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma

2005 • 1,613 citations

Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients

2006 • 1,180 citations

Immunogenic death of colon cancer cells treated with oxaliplatin

2009 • 1,041 citations

Dendritic cell immunotherapy: mapping the way

2004 • 948 citations

Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy

2005 • 807 citations

Immunotherapy and chemotherapy — a practical partnership

2005 • 639 citations

Generation of Human Cytotoxic T Cells Specific for Human Carcinoembryonic Antigen Epitopes From Patients Immunized With Recombinant Vaccinia-CEA Vaccine

1995 • 506 citations

Particular aspects of platinum compounds used at present in cancer treatment

2002 • 367 citations

Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients.

2003 • 323 citations

Gemcitabine exerts a selective effect on the humoral immune response: implications for combination chemo-immunotherapy.

2002 • 235 citations

Route of Immunization with Peptide-pulsed Dendritic Cells Controls the Distribution of Memory and Effector T Cells in Lymphoid Tissues and Determines the Pattern of Regional Tumor Control

2003 • 221 citations

Immunomonitoring Tumor-Specific T Cells in Delayed-Type Hypersensitivity Skin Biopsies After Dendritic Cell Vaccination Correlates With Clinical Outcome

2005 • 183 citations

Chemo-Immunotherapy of Metastatic Colorectal Carcinoma With Gemcitabine Plus FOLFOX 4 Followed by Subcutaneous Granulocyte Macrophage Colony-Stimulating Factor and Interleukin-2 Induces Strong Immunologic and Antitumor Activity in Metastatic Colon Cancer Patients

2005 • 165 citations

Phenotypical and Functional Characterization of Clinical Grade Dendritic Cells

2002 • 154 citations

Dendritic cell vaccines in melanoma: From promise to proof?

2008 • 120 citations

Combination Chemotherapy and ALVAC-CEA/B7.1 Vaccine in Patients with Metastatic Colorectal Cancer

2008 • 117 citations

Chemotherapy enhances vaccine‐induced antitumor immunity in melanoma patients

2008 • 100 citations

Vaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin tests

2006 • 94 citations

Vaccination of colorectal cancer patients with TroVax given alongside chemotherapy (5-fluorouracil, leukovorin and irinotecan) is safe and induces potent immune responses

2007 • 86 citations

Treatment of colon and breast carcinoma cells with 5‐fluorouracil enhances expression of carcinoembryonic antigen and susceptibility to HLA‐A(*)02.01 restricted, CEA‐peptide‐specific cytotoxic T cells in vitro

2003 • 80 citations

Phase I/II Combined Chemoimmunotherapy with Carcinoembryonic Antigen–Derived HLA-A2–Restricted CAP-1 Peptide and Irinotecan, 5-Fluorouracil, and Leucovorin in Patients with Primary Metastatic Colorectal Cancer

2005 • 65 citations

5-Fluorouracil–Based Chemotherapy Enhances the Antitumor Activity of a Thymidylate Synthase–Directed Polyepitopic Peptide Vaccine

2005 • 43 citations

Immunotherapy with dendritic cells and CpG oligonucleotides can be combined with chemotherapy without loss of efficacy in a mouse model of colon cancer

2005 • 42 citations

In situ detection of antigen-specific T cells in cryo-sections using MHC class I tetramers after dendritic cell vaccination of melanoma patients

2007 • 26 citations

Cited By (0)

No citing papers found in database

A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant… (2010) – British Journal of Cancer | Metascience Observatory Explorer